ROGEMOND; Veronique

Patent Applications and Registrations

Patent applications and USPTO patent grants for ROGEMOND; Veronique.The latest application filed is for "antibodies against trim9 and/or trim67 in paraneoplastic neurological syndromes".

Company Profile

2.5.7

ROGEMOND; Veronique - LYON FR
Rogemond; Veronique - Lyons FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies Against Trim9 And/or Trim67 In Paraneoplastic Neurological Syndromes App 20220178949 - DO; Le Duy ; et al.	2022-06-09
Novel Human Ulip/crmp Protein And Use Thereof In Diagnosis And Treatment Of Cancers And Paraneoplastic Neurological Syndromes App 20190119339 - AGUERA; Michele ; et al.	2019-04-25
Protein chips, preparation and use thereof Grant 10,168,327 - Lesage , et al. J	2019-01-01
Human ULIP/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes Grant 10,087,220 - Aguera , et al. October 2, 2	2018-10-02
Protein Chips, Preparation And Use Thereof App 20150018251 - Lesage; Florian ; et al.	2015-01-15
Novel Human Ulip/crmp Protein And Use Thereof In Diagnosis And Treatment Of Cancers And Paraneoplastic Neurological Syndromes App 20130243755 - AGUERA; Michele ; et al.	2013-09-19
Diagnosis of cancers and paraneoplastic neurological syndromes with novel human ULIP/CRMP protein Grant 8,377,645 - Aguera , et al. February 19, 2	2013-02-19
Novel human ulip/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes App 20080226636 - Aguera; Michele ; et al.	2008-09-18
Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes Grant 7,329,499 - Aguera , et al. February 12, 2	2008-02-12
Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes App 20030176336 - Aguera, Michele ; et al.	2003-09-18
Use of Ulip-and/or Ulip2 in the treatment of myelin disorders App 20020119944 - Aguera, Michelle ; et al.	2002-08-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.